The craziest thing about World Cup month is realizing where you were in life during the last one. Shit I still remember watching my first World Cup game ever. A 4-year gap means your job, your relationship status, your friends, and your entire life situation are completely different, but you're sitting watching a random group stage game at 1 AM on a Tuesday. Football is a time capsule.
@avidseries So working from this premise, is increasing the collective performance of black students a high-leverage opportunity to improve results across demographics and improve overall school quality?
People who don't follow cancer research often ask me why we haven't cured cancer. That perception masks a wonderful reality: We make amazing, stepwise progress every year, and the result is that many people live much longer today than they would have previously.
Right now we're in the thick of the annual meeting of the American Society of Clinical Oncology, the biggest research meeting on new cancer medicines, and this morning a bunch of really important studies dropped. I'm going to review them here.
This first image is the result for daraxonrasib, a treatment for pancreatic cancer that is generating consdirable excitement. The green line is the probability of living for patients who got the new drug; the gray one is the chemo control group.
If you follow cancer drugs, a chart like this will make your breath hitch a little. I'm going to review these and some other data here.
This has quietly been a miracle month in medicine.
In the last 5 weeks we’ve got news on:
- retatrutide, the triple agonist GLP-1 from Lilly, basically melting fat and body-wide inflammation at record levels
- RevMed’s new pancreatic cancer drug showing unprecedented abilities to extend life
- small trial of a one-and-done PCSK9 gene editing therapy for slashing LDL cholesterol
- Mayo’s AI-assisted radiology showing vastly improved cancer detection
- this new therapy for metastatic solid tumors
This stuff is at varying levels of evidence. Retatrutide is ~100% on its way, other stuff needs more clinical trial data. But put it together and we’re maybe on the verge of majorly reducing the mortality of heart disease and cancer, the two leading causes of death in America.
Looking for some weekend reading material? Check out CSBA's May newsletter, which includes a breakdown of Gov. Gavin Newsom’s May Budget Revise, as well as CSBA advocacy to demand Prop 98 education funding be protected in the final budget; progress related to the #SOSforStudentAchievement legislative package; and a recap of the Coast2Coast Federal Advocacy Trip! The latest edition of California School News also includes information on newly developed resources about supporting foster youth and the release of the Board Policy Development Toolkit, legal updates related to student free speech, a message from CSBA President Dr. Debra Schade on the importance of honoring students’ educational journeys as the academic year ends and more. Read it here: https://t.co/zqqbXG7lqG